Zobrazeno 1 - 10
of 87
pro vyhledávání: '"L. Bortot"'
Autor:
B. Lindstrom, P. Bélanger, L. Bortot, R. Denz, M. Mentink, E. Ravaioli, F. Rodriguez Mateos, R. Schmidt, J. Uythoven, M. Valette, A. Verweij, C. Wiesner, D. Wollmann, M. Zerlauth
Publikováno v:
Physical Review Accelerators and Beams, Vol 23, Iss 8, p 081001 (2020)
An energy of 362 MJ is stored in each of the two LHC proton beams for nominal beam parameters. This will be further increased to about 700 MJ in the future high luminosity LHC (HL-LHC) and uncontrolled beam losses represent a significant hazard for t
Externí odkaz:
https://doaj.org/article/64ea7b80b1e4497db0a3416fd0b5b5bc
Autor:
L. Bortot, D. Basile, L. Palmero, A. Dri, L. Cucciniello, S. Buriolla, B. Pastò, R. Mazzeo, M. Bonotto, S. Bolzonello, A. Franzoni, L. Allegri, B. Belletti, G. Damante, L. Gerratana, A.M.M. Minisini, F. Puglisi
Publikováno v:
Annals of Oncology. 33:S656-S657
Autor:
Mattia Garutti, Alessandro Marco Minisini, Lucia Da Ros, Giacomo Pelizzari, C. Lisanti, Marta Bonotto, Simon Spazzapan, Mauro Mansutti, Debora Avoledo, Lorenzo Gerratana, Silvia Bolzonello, M. Giavarra, Debora Basile, E. Bertoli, L. Bortot, Michele Bartoletti, Gianpiero Fasola, Fabio Puglisi, S. Buriolla, Paola Di Nardo, C. Corvaja
Publikováno v:
Cancer Research. 80:P5-14
Background: The combination of endocrine therapy with the cyclin-dependent kinases 4/6 inhibitor palbociclib was proven to be effective for the treatment of hormone receptor (HR)-positive/HER2-negative metastatic breast cancer (MBC). Although general
Publikováno v:
Sixth EAGE High Performance Computing Workshop.
Autor:
R. Mazzeo, B. Pastò, D. Basile, L. Bortot, L. Cucciniello, A. Dri, C. Noto, S. Buriolla, L. Palmero, A. Membrino, M. Bonotto, C. Lisanti, S. Russo, A.M.M. Minisini, G. Fasola, L. Gerratana, F. Puglisi
Publikováno v:
Annals of Oncology. 33:S641
Autor:
M. de Scordilli, L. Bortot, L. Cucciniello, F. Totaro, R. Mazzeo, M. Alberti, L. Palmero, G. Targato, A. Dri, F. Pravisano, G. Zapelloni, C. Lisanti, S. Spazzapan, A.M.M. Minisini, M. Mansutti, M. Bonotto, L. Gerratana, G. Fasola, F. Puglisi
Publikováno v:
Annals of Oncology. 33:S650
Autor:
Lorenzo Gerratana, Alessandra Franzoni, Lorenzo Allegri, G. Targato, A. Michelotti, L. Palmero, P. Di Nardo, G. Damante, S. Sodde, Barbara Belletti, M. Alberti, Gustavo Baldassarre, E. Bertoli, L. Bortot, Marta Bonotto, Simon Spazzapan, Roberta Mazzeo, L. Da Ros, F. Puglisi, S. Buriolla
Publikováno v:
Annals of Oncology. 32:S492-S493
Autor:
Renzo Barbazza, Serena Bonin, L. Bortot, Giorgio Stanta, Eros Azzalini, Fabio Puglisi, Vincenzo Canzonieri, Michele Bartoletti, Giorgio Giorda
Objective High grade serous ovarian carcinoma (HGSOC) is the most common type of malignant ovarian neoplasm and the main cause of ovarian cancer related deaths worldwide. Although novel biomarkers such as homologous recombination deficiency testing h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc52e4482ec6d6d17f69169f355b722
http://hdl.handle.net/11390/1213952
http://hdl.handle.net/11390/1213952
Publikováno v:
Fifth EAGE Workshop on High Performance Computing for Upstream.
Summary In industrial HPC applications, the maximization of the overall performance is a complex task: besides optimization aspects strictly related to numerical algorithms, many others must be taken into account. In particular, in addition to single
Autor:
Milena S. Nicoloso, Maria Grazia Vitale, Marta Bonotto, Serena Corsetti, Giorgio Giorda, Fabio Puglisi, Maria Luisa Meacci, Marco de Scordilli, Francesco Sopracordevole, Roberto Sorio, Simona Scalone, Michele Bartoletti, Gianpiero Fasola, Rocco De Vivo, Claudia Andreetta, Roberta Mazzeo, L. Bortot, Anna Del Fabro
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 30(11)
BackgroundInvasive vulvar Paget’s disease with over-expression of the human epidermal growth factor receptor 2 (HER2) protein is potentially suitable for targeted therapy, especially in a metastatic setting where no effective treatments are availab